Evotec has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets, aiming to drive operational excellence and eliminate manual expense reporting. The partnership will consolidate fragmented processes into a single, unified platform to support consistency, transparency, and efficiency for the global drug discovery and development company.

Historically, Evotec managed T&E independently across different countries, resulting in a patchwork of tools and manual offline processes for employees. By transitioning to Navan, the company intends to automate reconciliation directly from the point of swipe, reducing the need for manual entry and streamlining the user experience.

Strategic Rollout

Evotec is implementing the Navan platform across five primary markets: Germany, the UK, U.S., Italy, and France. This deployment focuses on enhancing the overall user experience while providing real-time visibility and control over global travel and expense activities.

Executive Perspectives

"Simplifying processes and strengthening operational excellence while enabling our employees with efficient tools are key priorities for Evotec," said Kay Prätorius, VP Procurement at Evotec. "Transitioning to the single, intuitive Navan platform will enhance the overall user experience, providing real-time visibility and control over our global travel and expense activities."

Zahir Abdelouhab, SVP, Enterprise Sales, EMEA at Navan, highlighted the efficiency gains associated with modernizing travel and expense systems. "Evotec is taking an important step in further streamlining and standardizing its processes and Navan is supporting this by bringing greater clarity and simplicity to travel and expense management, supporting teams in focusing on their core work."

Key Implementation Details

Kuehn Law, PLLC is investigating whether certain officers and directors of Navan, Inc. breached their fiduciary duties to shareholders. The investigation follows a federal securities lawsuit alleging that the company misrepresented its growth and revenue opportunities to investors. The lawsuit claims Navan emphasized rapid growth and solutions for customers of all sizes in its Offering Documents, stating revenue increased 33% year-over-year from 2024 to 2025, Gross Booking Volume increased 32% year-over-year from 2024 to 2025, and usage yield was approximately 7% in both years.

According to the lawsuit, Navan allegedly increased its sales and marketing expenses by 39% for the quarter ending October 31, 2025, reaching $95 million. This increase occurred on the same day as the company's Initial Public Offering, rising from $68.5 million in the previous quarter. The complaint asserts that this financial information was unbeknownst to investors at the time.

Alleged Misrepresentations

The lawsuit focuses on discrepancies between the company's public statements and its internal financial realities regarding growth and expenses. The key financial figures cited in the Offering Documents are detailed below:

Shareholder Action Required

Kuehn Law is encouraging shareholders who currently own Navan, Inc. and purchased shares prior to November 1, 2025, to contact the firm. Shareholders can reach Sophia Anne Silayan via email at sophiaanne@kuehn.law or by calling (833) 672-0814. The firm notes that it pays all case costs and does not charge its investor clients. Shareholders are advised to contact the firm immediately due to potential time limits on enforcing their rights.